Multiple myeloma and Corneal disorder
Corneal disorder is found among people with Multiple myeloma, especially for people who are male, 60+ old.
The study analyzes which people have Corneal disorder with Multiple myeloma. It is created by eHealthMe based on reports of 43 people who have Multiple myeloma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
43 people who have Multiple Myeloma and Corneal Disorder are studied.
What is Multiple myeloma?
Multiple myeloma (cancer of the plasma cells) is found to be associated with 2,101 drugs and 1,276 conditions by eHealthMe.
What is Corneal disorder?
Corneal disorder is found to be associated with 735 drugs and 418 conditions by eHealthMe.
Number of Corneal disorder in Multiple myeloma reports submitted per year:
Gender of people who have Multiple Myeloma and experienced Corneal Disorder *:
- female: 48.72 %
- male: 51.28 %
Age of people who have Multiple Myeloma and experienced Corneal Disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 5 %
- 50-59: 15 %
- 60+: 80 %
Common co-existing conditions for these people *:
- Pain: 2 people, 4.65%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 4.65%
- Drug Hypersensitivity: 2 people, 4.65%
- Neuropathy Peripheral (surface nerve damage): 1 person, 2.33%
- Insomnia (sleeplessness): 1 person, 2.33%
- High Blood Pressure: 1 person, 2.33%
- Depression: 1 person, 2.33%
- Cardiac Disorder: 1 person, 2.33%
- Amyloidosis (a tumour within which amyloid is produced): 1 person, 2.33%
Common drugs taken by these people *:
- Revlimid: 22 people, 51.16%
- Synthroid: 8 people, 18.60%
- Lipitor: 6 people, 13.95%
- Fish Oil: 5 people, 11.63%
- Vitamin D: 5 people, 11.63%
- Velcade: 5 people, 11.63%
- Lutein: 4 people, 9.30%
- Amlodipine: 4 people, 9.30%
- Magnesium: 4 people, 9.30%
- Dexamethasone: 3 people, 6.98%
Common symptoms for these people *:
- Visual Acuity Reduced (reduced clearness of vision): 12 people, 27.91%
- Keratopathy (noninflammatory disease of the cornea): 11 people, 25.58%
- Vision Blurred: 10 people, 23.26%
- Dry Eyes (lack of adequate tears): 7 people, 16.28%
- Visual Impairment: 5 people, 11.63%
- Fatigue (feeling of tiredness): 4 people, 9.30%
- Vision - Night Blindness: 4 people, 9.30%
- Eye Infection: 4 people, 9.30%
- Foreign Body Sensation In Eyes (feeling of something in eye): 4 people, 9.30%
- Ocular Toxicity (damages eye): 3 people, 6.98%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Corneal disorder?Check whether Corneal disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
- Multiple myeloma (442,002 reports)
- Corneal disorder (2,311 reports)
COVID vaccines that are related to Corneal disorder:
- Corneal disorder in Moderna COVID Vaccine
- Corneal disorder in Pfizer BioNTech Covid Vaccine
- Corneal disorder in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Corneal disorder:
- Corneal disorder (735 drugs)
Common conditions associated with Corneal disorder:
- Rheumatoid arthritis: 168 reports
- Glaucoma: 122 reports
All the conditions that are associated with Corneal disorder:
- Corneal disorder (418 conditions)
How the study uses the data?
The study is based on Corneal disorder and Multiple myeloma, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Meloxicam and Prevacid Iv drug interaction - 22 seconds ago
- Proteus Infection and Hyperkalemia - 23 seconds ago
- Ebrantil and Respiratory Distress - 29 seconds ago
- Pred Mild and Rheumatoid Arthritis Aggravated - 30 seconds ago
- Imdur and Vaginal Yeast Infection - 35 seconds ago
- Etodolac and Neuroendocrine Carcinoma Of The Skin - 41 seconds ago
- Pemetrexed Disodium and Rheumatoid Nodule - 41 seconds ago
- Percodan and Torecan drug interaction - 43 seconds ago
- Demadex and Glossitis - 51 seconds ago
- Decadron and Trulance drug interaction - 54 seconds ago